Page last updated: 2024-11-04

homarine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Homarine is a quaternary ammonium compound found in marine organisms, particularly in invertebrates like crustaceans and mollusks. It is synthesized from the amino acid arginine through a series of enzymatic reactions. Homarine has been shown to possess various pharmacological activities, including anti-inflammatory, antioxidant, and neuroprotective effects. Its role in marine organisms is not fully understood, but it is thought to be involved in osmoregulation and cellular signaling. Research on homarine is ongoing, with studies exploring its potential applications in medicine, agriculture, and biotechnology. One area of interest is its potential as a therapeutic agent for neurodegenerative diseases, such as Alzheimer's disease. '

homarine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3620
CHEBI ID69061
SCHEMBL ID272532
MeSH IDM0056931

Synonyms (25)

Synonym
homarine
nsc714351
nsc-714351
445-30-7
homarine-d3
2-carboxy-1-methylpyridinium inner salt
FT-0669219
1-methylpyridin-1-ium-2-carboxylate
AKOS006280030
1-methyl-2-pyridinecarboxylic acid
picolinic acid n-methylbetaine
unii-kq3vhx1490
kq3vhx1490 ,
betaine homarine
CHEBI:69061
1-methyl-2-pyridinium carboxylate
homarine [mi]
SCHEMBL272532
DTXSID10196201
1-methyl-2-pyridiniumcarboxylate
1-methyl-2-carboxypyridinium betaine
Q27137402
homarine; lc-tdda; ce10
2-carboxy-1-methylpyridinium, inner salt
STARBLD0030787

Research Excerpts

Overview

Homarine is an osmotic pressure regulator, morphogen, etc. Homarine is enzymatically synthesized by the methylation of picolinic acid with S-adenosyl-L-methionine.

ExcerptReferenceRelevance
"Homarine, which is an osmotic pressure regulator, morphogen, etc.; is enzymatically synthesized by the methylation of picolinic acid with S-adenosyl-L-methionine and the enzyme activity may be controlled by S-adenosyl-L-homocysteine (reaction product) and its related compounds."( Finding of a homarine-synthesizing enzyme in turban shell and some properties of the enzyme.
Kikuchi, S; Nishitani, H; Okumura, K; Taguchi, H, 1995
)
1.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (51.61)18.7374
1990's1 (3.23)18.2507
2000's5 (16.13)29.6817
2010's7 (22.58)24.3611
2020's2 (6.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.42 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index50.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]